Patient characteristics
| Characteristic . | Value . |
|---|---|
| Median age, y (range) | 65 (44-84) |
| No. male/female | 24/10 |
| No. with κ/λ isotype | 10/24 |
| More than 2 organs involved, no. (%) | 7 (21) |
| Cardiac involvement, no. (%) | 13 (38) |
| Elevated BNP levels, no. (%) | 17 (50) |
| Prior treatment, no. (%) | 31 (91) |
| With HDM/SCT | 19 (56) |
| With thalidomide | 7 (21) |
| Median no. of prior treatments (range) | 1 (0-5) |
| Characteristic . | Value . |
|---|---|
| Median age, y (range) | 65 (44-84) |
| No. male/female | 24/10 |
| No. with κ/λ isotype | 10/24 |
| More than 2 organs involved, no. (%) | 7 (21) |
| Cardiac involvement, no. (%) | 13 (38) |
| Elevated BNP levels, no. (%) | 17 (50) |
| Prior treatment, no. (%) | 31 (91) |
| With HDM/SCT | 19 (56) |
| With thalidomide | 7 (21) |
| Median no. of prior treatments (range) | 1 (0-5) |
BNP indicates brain natriuretic peptide; HDM/SCT, high-dose melphalan and autologous stem cell transplantation.